1 |
Baranowski AP, De Courcey J, Bonello E. A trial of intravenous lidocaine on the pain and allodynia of postherpetic neuralgia. J Pain Symptom Manage 1999; 17: 429-33.
DOI
ScienceOn
|
2 |
Tanelian DL, MacIver MB. Analgesic concentrations of lidocaine suppress tonic A-delta and C fiber discharges produced by acute injury. Anesthesiology 1991; 74: 934-6.
DOI
ScienceOn
|
3 |
Chabal C, Russell LC, Burchiel KJ. The effect of intravenous lidocaine, tocainide, and mexiletine on spontaneously active fibers originating in rat sciatic neuromas. Pain 1989; 38: 333-8.
DOI
ScienceOn
|
4 |
Woolf CJ, Wiesenfeld-Hallin Z. The systemic administration of local anaesthetics produces a selective depression of C-afferent fibre evoked activity in the spinal cord. Pain 1985; 23: 361-74.
DOI
ScienceOn
|
5 |
Nagy I, Woolf CJ. Lignocaine selectively reduces C fibreevoked neuronal activity in rat spinal cord in vitro by decreasing N-methyl-D-aspartate and neurokinin receptormediated post-synaptic depolarizations; implications for the development of novel centrally acting analgesics. Pain 1996; 64: 59-70.
DOI
ScienceOn
|
6 |
Jensen MP. Using pain quality assessment measures for selecting analgesic agents. Clin J Pain 2006; 22: S9-13.
DOI
ScienceOn
|
7 |
Carroll IR, Younger JW, Mackey SC. Pain quality predicts lidocaine analgesia among patients with suspected neuropathic pain. Pain Med 2010; 11: 617-21.
DOI
ScienceOn
|
8 |
Jensen MP, Dworkin RH, Gammaitoni AR, Olaleye DO, Oleka N, Galer BS. Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain Scale. J Pain 2005; 6: 98-106.
DOI
ScienceOn
|
9 |
Tremont-Lukats IW, Hutson PR, Backonja MM. A randomized, double-masked, placebo-controlled pilot trial of extended IV lidocaine infusion for relief of ongoing neuropathic pain. Clin J Pain 2006; 22: 266-71.
DOI
ScienceOn
|
10 |
Ellemann K, Sjögren P, Banning AM, Jensen TS, Smith T, Geertsen P. Trial of intravenous lidocaine on painful neuropathy in cancer patients. Clin J Pain 1989; 5: 291-4.
DOI
ScienceOn
|
11 |
Waguespack A, Schofferman J, Slosar P, Reynolds J. Etiology of long-term failures of lumbar spine surgery. Pain Med 2002; 3: 18-22.
DOI
ScienceOn
|
12 |
Ferrante FM, Paggioli J, Cherukuri S, Arthur GR. The analgesic response to intravenous lidocaine in the treatment of neuropathic pain. Anesth Analg 1996; 82: 91-7.
|
13 |
Mao J, Chen LL. Systemic lidocaine for neuropathic pain relief. Pain 2000; 87: 7-17.
DOI
ScienceOn
|
14 |
Onesti ST. Failed back syndrome. Neurologist 2004; 10: 259-64.
DOI
ScienceOn
|
15 |
Burton CV, Kirkaldy-Willis WH, Yong-Hing K, Heithoff KB. Causes of failure of surgery on the lumbar spine. Clin Orthop Relat Res 1981; 157: 191-9.
|
16 |
Dworkin RH, O'Connor AB, Audette J, Baron R, Gourlay GK, Haanpaa ML, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 2010; 85: S3-14.
|
17 |
Tremont-Lukats IW, Challapalli V, McNicol ED, Lau J, Carr DB. Systemic administration of local anesthetics to relieve neuropathic pain: a systematic review and meta-analysis. Anesth Analg 2005; 101: 1738-49.
|
18 |
Attal N, Gaude V, Brasseur L, Dupuy M, Guirimand F, Parker F, et al. Intravenous lidocaine in central pain: a double-blind, placebo-controlled, psychophysical study. Neurology 2000; 54: 564-74.
DOI
ScienceOn
|